Icon (ICLR) EBIT Growth (5y) (2014 - 2026)
Powered by 
Analysis
Icon (ICLR) EBIT Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.08% |
| Mar 31, 2026 | 8.41% |
| Dec 31, 2025 | 11.64% |
| Sep 30, 2025 | -4.39% |
| Jun 30, 2025 | 32.31% |
| Mar 31, 2025 | 22.18% |
| Dec 31, 2024 | 23.43% |
| Sep 30, 2024 | 21.00% |
| Jun 30, 2024 | 16.72% |
| Mar 31, 2024 | 22.87% |
| Dec 31, 2023 | 19.06% |
| Sep 30, 2023 | 21.96% |
| Jun 30, 2023 | 20.66% |
| Mar 31, 2023 | 18.77% |
| Dec 31, 2022 | 17.78% |
| Sep 30, 2022 | 23.47% |
| Jun 30, 2022 | 17.91% |
| Mar 31, 2022 | 14.74% |
| Dec 31, 2021 | 11.30% |
| Sep 30, 2021 | -41.89% |